CABP CE Bundle: 48 Credits (2025 and 2024 annual mtg on-demand sessions)

For Recertifying CABPs Only – Exclusive AABB CABP CE Bundle

This specially priced bundle is designed to support current Certified Advanced Biotherapies Professionals (CABPs) in fulfilling their continuing education (CE) requirement. It includes 40 programs that collectively offer 48 CABP CE-eligible credits.

All programs in this bundle are available online through AABB’s Education Platform as independent, self-paced learning programs. Upon purchase, you’ll receive immediate access via AABB’s Education Platform.

Important: Each program within the bundle has a specific expiration date. CE credit must be claimed before the expiration date of each individual program.

Programs included:

2025 Annual Meeting On-Demand Sessions (expire Dec. 31, 2027)

• AM25-ST-03-O: Quality Agreements in Cell Therapy: Building Successful Partnerships (Enduring)
• AM25-ST-09-O: CBC: How does Cord Blood Facilitate Tissue Repair and Regeneration? (Enduring)
• AM25-ST-10-O: CBC: Innovative Approaches in Cord Blood Transplantation: Clinical Outcomes and New Strategies (Enduring)
• AM25-ST-13-O: Think Like a Detective: Investigating Quality Issues with Root Cause Analysis (RCA) Tools (Enduring)
• AM25-ST-14-O: Allogeneic Transplant, Gene Therapy, or the Evolving Drug Landscape in Sickle Cell Disease: Helping Patients Choose Between Options (Enduring)
• AM25-ST-18-O: Ensuring Safe and Effective Distribution of Advanced Therapies: Unique Perspectives from Pharmacy and Cell Therapy Labs (Enduring)
• AM25-ST-20-O: CBC: Opportunities & Challenges the Field of Cord Blood and Birthing Tissues (Enduring)
• AM25-ST-23-O: CBC: The New Frontiers of MSC´s in Regenerative Medicine (Enduring)
• AM25-SN-01-O: CBC: Emerging Issues in Cord Blood Therapeutics and Gene Therapies (President’s Session) (Enduring)
• AM25-SN-07-O: Expanding CGT Access: The Role of Blood Centers in Last-Mile Delivery (Enduring)
• AM25-SN-10-O: Implementation of Lab Automation: Best Practices and Benefits (Enduring)
• AM25-SN-15-O: Evolving Immunologic Concepts – From Basic Mechanisms to Translation (Enduring)
• AM25-SN-17-O: CBC: Defining Novel Growth Opportunities for the Cord Blood Field: Lessons Learned & Pathways Forward (Enduring)
• AM25-SN-18-O: Ensuring Ethical and Regulatory Compliance in Donor Collections for Advanced Therapies (Enduring)
• AM25-SN-19-O: CBC: Exploring the Unique Biology of Cord Blood and Birthing Tissues (Enduring)
• AM25-SN-21-O: Novel Tools and Platform Designs in Biotherapies (Enduring)
• AM25-SN-27-O: Revolutionizing Donor Selection: Integrating AI, Omics Data, and Large-Scale Cohorts for Improved Cell Therapy Outcomes (Enduring)
• AM25-SN-33-O: CBC: Evidence Based Communication in Cord Blood Donation and Banking (Enduring)
• AM25-SN-35-O: Basic Blood Biology and Mechanisms of Immunity in Transfusion Medicine and Biotherapies (Enduring)
• AM25-MN-02-O: CBC: Lightning Talks – The Future of Cord Blood: Bold Visions & Innovations (Enduring)
• AM25-MN-03-O: CBC: A New Era for Cord Blood - The National Cord Blood Network (Enduring)
• AM25-MN-07-O: Cell Therapy Lab Jeopardy! (Enduring)
• AM25-MN-11-O: From Blueprint to Benchmark: A Journey Through AABB Standards Development and Accreditation (Enduring)
• AM25-MN-14-O: Advancing Cord Blood Utilization: Building Pathways for Innovation and Clinical Adoption (Enduring)
• AM25-MN-18-O: Oral Abstract Session - Advances in Cord Blood Therapy (Enduring)
• AM25-MN-22-O: CBC: State of the Science Symposium – Striking a New Cord in the Evolution of Stem Cell Transplant (Enduring)
• AM25-MN-23-O: The Top Nonconformances Stratified by Facility Size and Location. Where Do You Fit? (Enduring)
• AM25-MN-27-O: Ask the Standards (Enduring)
• AM25-MN-29-O: Unlocking the Power of Extracellular Vesicles: From Intercellular Communication to Therapeutic Innovation (Enduring)
• AM25-MN-39-O: Research and Progress (RAPS): Organoids in Research and Biotherapies: Promise, Progress, and Challenges (Enduring)
• AM25-TU-10-O: Transfusion Medicine, Hemostasis, Apheresis, and Cellular Therapy Review Session for Trainees (Enduring)
• AM25-TU-13-O: 2025 Ask the FDA and CMS/CLIA (Enduring)
• AM25-TU-15-O: Oral Abstract Spotlight Session - Biotherapies & Cell Transplantation (Enduring)
• AM25-TU-16-O: Building a Translational Arm to Your Cellular Therapy Laboratory (Enduring)
• AM25-TU-18-O: Why, When and How Should You Use Electronic Batch Records (EBRs) in the Cell and Gene Therapy Manufacturing Process (Enduring)

2024 Annual Meeting On-Demand Sessions (expire Dec. 31, 2026)

• AM24-ST-09-O: Sterility Testing for Cellular Therapies: Updates and Challenges. What Should We Be Doing? (Enduring)
• AM24-SN-17-O: Sickle Cell Disease: Inching Towards Transfusion Independence. Exploring the Journey from Chronic Transfusions to the Novel Biotherapeutics (Enduring)
• AM24-SN-19-O: Viral Vector Systems and Cellular Therapy (Enduring)
• AM24-MN-26-O: Overview of Cell-Based Biologics Manufacturing as a Contracted Service (Enduring)
• AM24-MN-31-O: Cell Therapy: Creative Inventory Management & Discard (Enduring)